helpline 01494 601 400
enquiries 01494 601 300

GPs report decline in childhood epilepsy

Epilepsy Society’s medical director, Professor Ley Sander believes the downwards trend is most likely due to better pre-natal and peri-natal care and delivery.

New report links epilepsy drug to autism

Children whose mothers take the drug sodium valproate while pregnant are at significantly increased risk of autism and other neurodevelopmental disorders, says report.

Chilled brain could mean fewer seizures

Mild cooling of the brain after a head injury could prevent the development of epileptic seizures, say researchers.

Genes linked to rare epilepsy

Researchers are mapping genes responsible for a rare form of epilepsy known as autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE).

Midazolam name change

The epilepsy emergency medication Epistatus has changed its name.

Epanutin infatabs - new patient information

Pfizer issues new guidelines on how to take Epanutin infatabs.

Changes to Epanutin - phenytoin - capsules

Phenytoin (current brand name Epanutin) transfers from one pharmaceutical company (Pfizer) to another (Flynn Pharma ltd).

Epanutin (phenytoin) capsules - new branding

Phenytoin (Epanutin) transfers from Pfizer to Flynn Pharma Ltd.

Epistatus (buccal midazolam) - changes to syringe

Emergency medication Epistatus (buccal midazolam), is going through changes to the syringe. 

Zonegran (zonisamide) licensed as monotherapy

Epilepsy drug Zonegran (zonisamide) is licensed for use as monotherapy.


Subscribe to Epilepsy Society RSS